May 2026·14 min read
If your SPV investment doesn’t add up, the same set of facts will often support several different legal theories at once. This guide walks through the ten claims that come up most often in SPV fraud matters — what each one means, what evidence supports it, and where the typical pitfalls are. It is written for investors trying to make sense of their situation, not as legal advice.
Start here: the gap between what was promised and what you got
Most SPV fraud claims begin the same way. An investor reviews their position around a liquidity event, a capital call, or a quarterly statement, and notices a gap. The price they paid does not match the fund’s own acquisition cost. The shares the fund said it owned cannot be confirmed. A fee that was disclosed at 2% turns out to compound through three affiliated entities. The IPO that was “imminent” never came. The gap is what triggers everything else. Before any legal theory is in play, your starting question is whether the offering materials, side letters, and oral representations you relied on actually described what happened. That is a factual exercise — gathering documents, reconstructing timelines, and comparing what was said against what occurred. Once those facts are organized, multiple legal theories typically apply at once. The list below is not exhaustive, and it is not legal advice. It is a plain-language explanation of the categories of claim that recur most often in SPV matters our team analyzes.
Rule 10b-5 securities fraud: the federal workhorse
Rule 10b-5, promulgated under Section 10(b) of the Securities Exchange Act of 1934, is the most frequently invoked private cause of action in SPV fraud cases. Distilled, it prohibits making material misstatements or material omissions in connection with the purchase or sale of a security, where the speaker acted with scienter (intent or recklessness), and the investor relied on the misstatement to their detriment. SPV interests are securities for these purposes, and most SPV offerings involve repeated affirmative representations — about ownership of underlying shares, about pricing, about fees, about the issuer relationship. When those representations turn out to be materially false, or when material facts were omitted in a way that made the affirmative statements misleading, Rule 10b-5 is generally the first theory considered. Federal court is the typical venue. Class actions are common where many investors received the same offering materials.
Common law fraud and fraudulent inducement
State common law fraud claims run parallel to Rule 10b-5 and often appear in the same complaint. The elements vary slightly by jurisdiction but generally require a false representation of material fact, knowledge of its falsity (or reckless disregard), intent that the investor rely on it, justifiable reliance, and resulting damages. “Fraudulent inducement” is a specific application of common law fraud focused on misrepresentations that caused the investor to enter the transaction in the first place. In SPV matters, this often centers on representations about the SPV’s relationship with the underlying company, the fund’s track record, or the structure of the offering. State law claims are useful because they are not constrained by some of the federal-court pleading requirements that apply to Rule 10b-5 (notably the heightened pleading standard under the Private Securities Litigation Reform Act).
Negligent misrepresentation
Where the evidence supports a misrepresentation but falls short of proving scienter, negligent misrepresentation often becomes the backstop theory. The elements are similar to common law fraud, except instead of knowing or reckless conduct, the standard is whether the defendant failed to exercise reasonable care in providing the information. This claim is particularly relevant where SPV sponsors made representations about valuations or anticipated liquidity events that turned out to be materially wrong but where intentional deception is hard to prove. Jurisdictions vary substantially in how broadly they recognize negligent misrepresentation, and some require a special relationship (for example, fiduciary or quasi-fiduciary) between speaker and recipient.
Fraud by omission and material omissions
Not every actionable misstatement is an affirmative falsehood. Investors are often misled by what an SPV did not tell them. Under both federal and state law, an omission can support a fraud claim where there was a duty to disclose. That duty arises in several contexts: where partial disclosure made a half-truth misleading, where a fiduciary or quasi-fiduciary relationship existed, or where statutory disclosure obligations applied (Rule 10b-5 again, or Regulation D requirements in private placements). In SPV matters, the recurring omission categories are: failure to disclose transfer restrictions or issuer-approval requirements; failure to disclose dilution or liquidation-preference mechanics; failure to disclose side letters granting preferential terms to other investors; failure to disclose the SPV’s actual acquisition cost compared to investor entry price; and failure to disclose conflicts between the sponsor and affiliated service providers.
Breach of fiduciary duty
Most SPV sponsors and general partners owe fiduciary duties to their investors. The scope and stringency of those duties depend on the entity form (LLC, limited partnership) and the operating documents — which often attempt to waive or limit fiduciary obligations. Where fiduciary duties survive, an SPV manager who self-deals, takes undisclosed economic benefits, layers undisclosed fees, or favors certain investors over others may face a fiduciary breach claim. This theory is particularly important because it can survive even where misrepresentation is hard to prove: the question is not what the manager said, but what the manager did with the trust placed in them. Damages in fiduciary breach claims sometimes extend beyond out-of-pocket loss to include disgorgement of profits the manager improperly received.
Rescission
Rescission is not exactly a cause of action; it is a remedy. The investor asks the court (or arbitrator) to unwind the transaction and put both parties back where they would have been if the deal had not happened. This is particularly valuable where the SPV’s losses are quantifiable but recovery would be straightforward if the entire transaction were simply rolled back — for example, where the offering materials misrepresented ownership of underlying shares the SPV never actually held. Rescission is generally available where the investor can show fraud in the inducement or, in some jurisdictions, material misrepresentation regardless of scienter. The investor must typically tender back any consideration received in connection with the investment.
Unjust enrichment
Unjust enrichment is a quasi-contractual theory: the defendant received a benefit at the plaintiff’s expense, and equity requires its return. In SPV matters, this typically arises where the sponsor retained undisclosed economics — the spread between investor entry price and the SPV’s acquisition cost, undisclosed placement fees paid by the issuer, or affiliate compensation hidden in the fee waterfall. The advantage of unjust enrichment is that it does not require proof of misrepresentation or scienter. The disadvantage is that it usually cannot be pled where an express contract governs the relationship — so its availability depends on the specific contract structure between investor and SPV.
Conversion
Conversion is the civil tort analogue to theft: the defendant exercised wrongful dominion over property belonging to the plaintiff. In SPV fraud matters, conversion shows up where investor funds were diverted from their stated purpose — for example, where the offering materials said capital would be used to acquire specific shares but the sponsor used it for operating expenses, personal expenses, or unrelated investments. Conversion claims often accompany fraud claims and provide a meaningful damages anchor: the measure of damages is typically the full value of the property converted, plus consequential damages.
State deceptive trade practice statutes
Most states have consumer-protection or deceptive trade practice statutes that apply, in varying degrees, to investment transactions. California’s Unfair Competition Law (Bus. & Prof. Code § 17200), New York’s General Business Law § 349, and similar statutes in other states can sometimes provide standalone causes of action against SPV sponsors. These claims often carry attorney’s fee provisions and, in some cases, statutory damages multipliers. Their availability against private-securities transactions varies by jurisdiction, and securities-specific exemptions can foreclose them in certain settings — but they are routinely worth analyzing alongside the core securities claims.
Why the same facts often support multiple theories
A single set of SPV facts will typically support several of these theories simultaneously. A sponsor who misrepresented the SPV’s acquisition cost, while taking an undisclosed spread, while failing to disclose transfer restrictions, while owing fiduciary duties to limited partners, may face: Rule 10b-5 securities fraud (the misstatement); common law fraud (state-law parallel); fraud by omission (the undisclosed spread, transfer restrictions, and side letters); breach of fiduciary duty (the self-dealing); unjust enrichment (the retained spread); and possibly negligent misrepresentation as a backstop. Sophisticated complaints plead these theories together because each one carries different elements, different defenses, different damages measures, and different statutes of limitations. A defendant who escapes one theory often does not escape all of them.
The statute of limitations clock
Investors waiting for an IPO, a liquidity event, or simply better information often delay action longer than they should. Most relevant statutes of limitations begin to run when the investor knew or should have known of the underlying facts — not when the loss was finally quantified. Rule 10b-5 claims have a two-year discovery period and a five-year repose period from the conduct itself. State common law fraud limitations periods range from two to six years depending on jurisdiction. Fiduciary breach claims often have shorter limitations periods than fraud claims. Conversion is commonly three to four years. The practical implication: if you suspect SPV fraud, the time to begin documenting and organizing is now, regardless of whether you ultimately decide to pursue a claim.
What investors should do first
Before any legal step, the analytical work matters most. Gather the offering documents: subscription agreement, private placement memorandum, side letters, any presentations or marketing materials, capital call notices, K-1s, and all email correspondence with the sponsor. Build a timeline of what was represented and when. Compare the representations against any external evidence of the underlying facts — Cap-table data, secondary-market pricing, the issuer’s filings if public, or publicly reported transactions involving the same shares. Identify the specific representations that turned out to be inaccurate, and document the materiality of each. This is the work our team does for investors evaluating their options. The output is a factual analysis an investor can use to decide whether to engage securities counsel, to negotiate with the sponsor directly, to coordinate with other affected investors, or in some cases, to walk away.
When to involve a securities attorney
We are not a law firm. If your situation involves actual or contemplated legal action, you should engage a qualified securities attorney. Our role is to prepare the factual and analytical groundwork investors typically need before that engagement is productive — so that counsel can move quickly when retained, and so investors can make an informed decision about whether litigation, arbitration, regulatory complaint, or private negotiation is the right next step for their specific circumstances. Most experienced securities attorneys work on contingency in investor-side matters where the merits and damages support it. Defense work is typically billed hourly. Either way, well-organized facts shorten the engagement, sharpen the strategy, and improve outcomes.
Concerned about an SPV investment?
Our risk reviews are complimentary and confidential.
Request a Confidential Risk Review →This article is for general informational purposes only. If your situation involves potential or active litigation, consult a qualified attorney for advice on your specific facts.